Are FDA And CMS Growing Apart? AEI’s Gottlieb Thinks So
Executive Summary
While many pharmaceutical industry observers like to talk about the new ways in which FDA and CMS are working together and sharing information, Scott Gottlieb is offering a contrarian view on relations between the two agencies
You may also be interested in...
Heads Of FDA, CMS And Other HHS Agencies May Be Named Within A Few Weeks
HHS Secretary-nominee Tom Daschle tells Senate HELP Committee there needs to be better coordination within the department.
Baucus Wants To Keep Comparative Effectiveness Separate From Cost Control
One of the first skirmishes in the 2009 health care reform debate is likely to occur over comparative effectiveness
Hypertensives May Get Class Outcome Labels; Industry Wary Of Broad Efficacy
Two major drug companies with significant hypertension profiles are welcoming the proposed inclusion of class-wide cardiovascular outcomes data in antihypertensive drug labeling - in contrast to other firms that commented on the FDA draft guidance